Clinical Trial: A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144111) titled 'A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib' on Aug. 20.

Brief Summary: This open-label study will evaluate the effect on the pharmacokinetics (PK), safety, and tolerability of a single oral dose of inavolisib in participants with moderate or severe hepatic impairment compared with demographically matched healthy participants with normal hepatic function.

Study Start Date: Aug. 25

Study Type: INTERVENTIONAL

Condition: Hepatic Impairment

Intervention: DRUG: Inavolisib

Participants will receive a single oral dose of inavolisib

Recruitment Status: NOT_YET_RE...